Development of risk stratification kit and small molecular anticancer drug by biomarker of gastric cancer

胃癌生物标志物危险分层试剂盒及小分子抗癌药物的开发

• 批准号: 26461984
• 负责人: OSHIMA Takashi
• 金额: $ 3.08万
• 依托单位: Yokohama City University
• 依托单位国家: 日本
• 项目类别: Grant-in-Aid for Scientific Research (C)
• 财政年份: 2014
• 资助国家: 日本
• 起止时间: 2014-04-01 至 2017-03-31
• 项目状态: 已结题
• 来源: https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-26461984/
• 关键词: 胃癌; バイオマーカー; 新規ターゲット; リスク層別化キット; 低分子抗癌剤

项目成果

Clinical significance of INHBA gene expression in patients with gastric cancer who underwent curative resection followed by adjuvant chemotherapy with S-1

胃癌根治性切除术后S-1辅助化疗患者INHBA基因表达的临床意义

• 发表时间: 2017
• 期刊: IN VIVO
• 影响因子: 2.3
• 作者: Katayama Y;Oshima T;Sakamaki K;Aoyama T;Hayashi T;Yamada T;Sato T;Yamamoto Y;Kunisaki C;Shiozawa M;Yoshikawa T;Akaike M;Rino Y;Imada T;Masuda M
• 通讯作者: Masuda M

Stratification Markers for the Risk of Recurrence after Curative Resection of Stage II or III Gastric Cancer and Potential Clinical Applications

II期或III期胃癌根治性切除后复发风险的分层标志物及潜在的临床应用

• 发表时间: 2015
• 作者: Oshima T;Sakamaki K;Miyagi Y;Cho H;Shiozawa M;Yoshikawa T;Rino Y;Kunisaki C;Tuburaya A Imada T;Masuda M
• 通讯作者: Masuda M

Assessment of Recurrence Risk Stratification Markers after Resection of Stage II or III Gastric Cancer and Potential Clinical Applications.

II 期或 III 期胃癌切除后复发风险分层标志物的评估和潜在的临床应用。

• 发表时间: 2014
• 作者: Oshima T;Sakamaki K;Miyagi Y;Shiozawa M;Kunisaki C;Yoshikawa T;Rino Y;Imada T;Masuda M
• 通讯作者: Masuda M

腫瘍内科

肿瘤学

• 发表时间: 2015
• 作者: Oshima T;Sakamaki K;Miyagi Y;Shiozawa M;Kunisaki C;Yoshikawa T;Rino Y;Imada T;Masuda M;大島 貴，吉川貴己
• 通讯作者: 大島 貴，吉川貴己

Stratification Markers for Risk of Recarrence after curative Resection of Stage II or III Gastric Cancer and Potential Clinical Applications.

II 期或 III 期胃癌治愈性切除后复发风险的分层标志物和潜在的临床应用。

• 发表时间: 2015
• 作者: Oshima T;Sakamaki K;Miyagi Y;Cho H;Shiozawa M;Yoshikawa T;Rino Y;Kunisaki C;Tuburaya A;Imada T;Masuda M
• 通讯作者: Masuda M